Biorestorative Therapies News

Promising Early Phase 2 Results for BioRestorative Therapies' BRTX-100 Lead to Buy Rating

TipRanksFeb 6 14:46 ET

Roth MKM Reiterates Buy on BioRestorative Therapies, Maintains $15 Price Target

BenzingaAug 14, 2023 09:51 ET

BioRestorative Therapies Analyst Ratings

BenzingaAug 14, 2023 09:50 ET

Analysts' Top Healthcare Picks: Ascendis Pharma (ASND), BioRestorative Therapies (BRTX)

TipRanksJun 28, 2023 11:50 ET

Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and BioRestorative Therapies (BRTX)

TipRanksMay 9, 2023 12:16 ET

BioRestorative Therapies (BRTX) Gets a Buy From Maxim Group

TipRanksApr 26, 2023 15:38 ET

Maxim Group Keeps Their Buy Rating on BioRestorative Therapies (BRTX)

TipRanksApr 1, 2023 07:35 ET

Maxim Group Keeps Their Buy Rating on BioRestorative Therapies (BRTX)

TipRanksMar 3, 2023 12:21 ET

BioRestorative Therapies Analyst Ratings

Benzinga Analyst RatingsDec 7, 2022 08:14 ET

Roth Capital Initiates Coverage On BioRestorative Therapies With Buy Rating, Announces Price Target of $15

Benzinga Real-time NewsDec 7, 2022 08:14 ET

Maxim Starts BioRestorative Therapies at Buy With $6 Price Target

MT NewswiresSep 28, 2022 08:26 ET